The 2009-2014 Outlook for Molecular Diagnostics in Greater China (Related Reports)

The 2009-2014 Outlook for Molecular Diagnostics in Greater China


December 2, 2008
141 Pages - SKU: ICN2097213
License type:
Online Download      US $495.00
Global Site License      US $990.00
The Market and Potential for Molecular Point of Care Diagnostics
2/5/2014 | published by: Kalorama Information
 The molecular diagnostic market and the point-of-care (POC) testing markets are two of the fastest growing segments of the overall IVD market. Historically, these have been completely different market segments.  Not anymore.  There has been  |  read more...
$3,995.00
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014 Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today 231  |  read more...
$5,622.50
Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2014
3/25/2014 | published by: BioSeeker Group AB
Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2014 Extra value: One year of free online updates included with this product There are today at least 285 nucleic acid drugs known to affect more than 223 specific  |  read more...
$5,622.50
2014 Strategies for the Italian Diagnostics Market
1/29/2014 | published by: Venture Planning Group
2014 Strategies for the Italian Diagnostics Market This new report from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading  |  read more...
$4,850.00
2014 Strategies for the Japanese Diagnostics Market
1/29/2014 | published by: Venture Planning Group
2014 Strategies for the Japanese Diagnostics Market This new report from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading  |  read more...
$4,850.00
2014 Strategies for the UK Diagnostics Market
1/29/2014 | published by: Venture Planning Group
2014 Strategies for the UK Diagnostics Market This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading  |  read more...
$4,850.00
Worldwide Molecular Diagnostics and DNA Sequencing Market 2014: Facilities, Test Volumes, and Sales Forecasts by Country (DataPack)
2/25/2014 | published by: Venture Planning Group
Worldwide Molecular Diagnostics and DNA Sequencing Market 2014: Facilities, Test Volumes, and Sales Forecasts by Country (DataPack) This report provides: Estimates of  |  read more...
$1,500.00
2014 Strategies for the French Nucleic Acid Testing Market
1/28/2014 | published by: Venture Planning Group
2014 Strategies for the French Nucleic Acid Testing Market Highlights Comprehensive 850-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, social and  |  read more...
$6,700.00
German Molecular Diagnostics and NAT Market 2014: Sales Forecasts and Key Supplier Shares (DataPack)
2/25/2014 | published by: Venture Planning Group
German Molecular Diagnostics and NAT Market 2014: Sales Forecasts and Key Supplier Shares (DataPack) This report provides: Five-year sales forecasts for  |  read more...
$1,500.00
2014 Strategies for the German Nucleic Acid Testing Market
1/28/2014 | published by: Venture Planning Group
2014 Strategies for the German Nucleic Acid Testing Market Highlights Comprehensive 850-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory,  |  read more...
$6,700.00